A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma

por Lewin, J, Khamly, K K, Young, R J, Mitchell, C, Hicks, R J, Toner, G C, Ngan, S Y K, Chander, S, Powell, G J, Herschtal, A, Te Marvelde, L, Desai, J, Choong, P F M, Stacker, S A, Achen, M G, Ferris, N, Fox, S, Slavin, J, Thomas, D M
Publicado 2014

Early Growth Response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer

por Baron, V T, Pio, R, Jia, Z, Mercola, D
Publicado 2015

Surgical staging and prognosis in serous borderline ovarian tumours (BOT): A subanalysis of the AGO ROBOT study

por Trillsch, F, Mahner, S, Vettorazzi, E, Woelber, L, Reuss, A, Baumann, K, Keyver-Paik, M-D, Canzler, U, Wollschlaeger, K, Forner, D, Pfisterer, J, Schroeder, W, Muenstedt, K, Richter, B, Fotopoulou, C, Schmalfeldt, B, Burges, A, Ewald-Riegler, N, de Gregorio, N, Hilpert, F, Fehm, T, Meier, W, Hillemanns, P, Hanker, L, Hasenburg, A, Strauss, H-G, Hellriegel, M, Wimberger, P, Kommoss, S, Kommoss, F, Hauptmann, S, du Bois, A
Publicado 2015

A first-in-human phase I, dose-escalation, multicentre study of HSP990 administered orally in adult patients with advanced solid malignancies

por Spreafico, A, Delord, J-P, De Mattos-Arruda, L, Berge, Y, Rodon, J, Cottura, E, Bedard, P L, Akimov, M, Lu, H, Pain, S, Kaag, A, Siu, L L, Cortes, J
Publicado 2015

hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma

por Lastraioli, E, Perrone, G, Sette, A, Fiore, A, Crociani, O, Manoli, S, D'Amico, M, Masselli, M, Iorio, J, Callea, M, Borzomati, D, Nappo, G, Bartolozzi, F, Santini, D, Bencini, L, Farsi, M, Boni, L, Di Costanzo, F, Schwab, A, Onetti Muda, A, Coppola, R, Arcangeli, A
Publicado 2015

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels

por Rondeau, S, Vacher, S, De Koning, L, Briaux, A, Schnitzler, A, Chemlali, W, Callens, C, Lidereau, R, Bièche, I
Publicado 2015

Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer

por Chen, Z-Y, Raghav, K, Lieu, C H, Jiang, Z-Q, Eng, C, Vauthey, J-N, Chang, G J, Qiao, W, Morris, J, Hong, D, Hoff, P, Tran, H, Menter, D G, Heymach, J, Overman, M, Kopetz, S
Publicado 2015

Fruit and vegetable consumption in relation to hepatocellular carcinoma in a multi-centre, European cohort study

por Bamia, C, Lagiou, P, Jenab, M, Aleksandrova, K, Fedirko, V, Trichopoulos, D, Overvad, K, Tjønneland, A, Olsen, A, Clavel-Chapelon, F, Boutron-Ruault, M-C, Kvaskoff, M, Katzke, V A, Kühn, T, Boeing, H, Nöthlings, U, Palli, D, Sieri, S, Panico, S, Tumino, R, Naccarati, A, Bueno-de-Mesquita, HB(as), Peeters, P H M, Weiderpass, E, Skeie, G, Quirós, J R, Agudo, A, Chirlaque, M-D, Sanchez, M-J, Ardanaz, E, Dorronsoro, M, Ericson, U, Nilsson, L M, Wennberg, M, Khaw, K-T, Wareham, N, Key, T J, Travis, R C, Ferrari, P, Stepien, M, Duarte-Salles, T, Norat, T, Murphy, N, Riboli, E, Trichopoulou, A
Publicado 2015

An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study

por Li, K, Hüsing, A, Fortner, R T, Tjønneland, A, Hansen, L, Dossus, L, Chang-Claude, J, Bergmann, M, Steffen, A, Bamia, C, Trichopoulos, D, Trichopoulou, A, Palli, D, Mattiello, A, Agnoli, C, Tumino, R, Onland-Moret, N C, Peeters, P H, Bueno-de-Mesquita, H B(as), Gram, I T, Weiderpass, E, Sánchez-Cantalejo, E, Chirlaque, M-D, Duell, E J, Ardanaz, E, Idahl, A, Lundin, E, Khaw, K-T, Travis, R C, Merritt, M A, Gunter, M J, Riboli, E, Ferrari, P, Terry, K, Cramer, D, Kaaks, R
Publicado 2015

Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA)

por Petrick, J L, Steck, S E, Bradshaw, P T, Trivers, K F, Abrahamson, P E, Engel, L S, He, K, Chow, W-H, Mayne, S T, Risch, H A, Vaughan, T L, Gammon, M D
Publicado 2015

Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project

por McGlynn, K A, Sahasrabuddhe, V V, Campbell, P T, Graubard, B I, Chen, J, Schwartz, L M, Petrick, J L, Alavanja, M C, Andreotti, G, Boggs, D A, Buring, J E, Chan, A T, Freedman, N D, Gapstur, S M, Hollenbeck, A R, Hou, L, King, L Y, Koshiol, J, Linet, M, Palmer, J R, Poynter, J N, Purdue, M, Robien, K, Schairer, C, Sesso, H D, Sigurdson, A, Wactawski-Wende, J, Zeleniuch-Jacquotte, A
Publicado 2015

Circulating cytokines and monocyte subpopulations as biomarkers of outcome and biological activity in sunitinib-treated patients with advanced neuroendocrine tumours

por Zurita, A J, Khajavi, M, Wu, H-K, Tye, L, Huang, X, Kulke, M H, Lenz, H-J, Meropol, N J, Carley, W, DePrimo, S E, Lin, E, Wang, X, Harmon, C S, Heymach, J V
Publicado 2015

Cancer-specific variation in emergency presentation by sex, age and deprivation across 27 common and rarer cancers

por Abel, G A, Shelton, J, Johnson, S, Elliss-Brookes, L, Lyratzopoulos, G
Publicado 2015

Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial

por Irving, Glen RB, Iwuji, Chinenye OO, Morgan, Bruno, Berry, David P, Steward, William P, Thomas, Anne, Brown, Karen, Howells, Lynne M
Publicado 2015

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II...

por Algazi, A P, Cha, E, Ortiz-Urda, S M, McCalmont, T, Bastian, B C, Hwang, J, Pampaloni, M H, Behr, S, Chong, K, Cortez, B, Quiroz, A, Coakley, F, Liu, S, Daud, A I
Publicado 2015

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

por Mahon, K L, Lin, H-M, Castillo, L, Lee, B Y, Lee-Ng, M, Chatfield, M D, Chiam, K, Breit, S N, Brown, D A, Molloy, M P, Marx, G M, Pavlakis, N, Boyer, M J, Stockler, M R, Daly, R J, Henshall, S M, Horvath, L G
Publicado 2015

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer...

por Fitzal, F, Filipits, M, Rudas, M, Greil, R, Dietze, O, Samonigg, H, Lax, S, Herz, W, Dubsky, P, Bartsch, R, Kronenwett, R, Gnant, M
Publicado 2015

Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies

por Collaborative Group on Epidemiological Studies of Ovarian Cancer
Publicado 2015

Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladder

por Hafeez, S, Horwich, A, Omar, O, Mohammed, K, Thompson, A, Kumar, P, Khoo, V, Van As, N, Eeles, R, Dearnaley, D, Huddart, R
Publicado 2015

A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis

por Biselli, M, Conti, F, Gramenzi, A, Frigerio, M, Cucchetti, A, Fatti, G, D'Angelo, M, Dall'Agata, M, Giannini, E G, Farinati, F, Ciccarese, F, Andreone, P, Bernardi, M, Trevisani, F
Publicado 2015